Elsevier

Fertility and Sterility

Volume 74, Issue 4, October 2000, Pages 743-748
Fertility and Sterility

Reproductive endocrinology
Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination

https://doi.org/10.1016/S0015-0282(00)01500-4Get rights and content
Under an Elsevier user license
open archive

Abstract

Objective: To assess the indications, effectiveness, and complications of ovarian transposition before pelvic irradiation for cervical cancer.

Design: Prospective study.

Setting: Gynecologic oncology department at a French cancer center.

Patient(s): One hundred seven patients treated for cervical cancer.

Intervention(s): Ovarian transposition to the paracolic gutters with radical hysterectomy and lymphadenectomy.

Main Outcome Measure(s): Clinical and laboratory follow-up tests for ovarian function.

Result(s): Bilateral ovarian transposition was achieved in 104 patients (98%). Twelve patients were lost to follow-up or excluded because of evolution of the disease. Preservation of ovarian function was achieved in 83% of the patients having follow-up. The rates of ovarian preservation were 100% for patients treated exclusively by surgery, 90% for patients treated by postoperative vaginal brachytherapy, and 60% for patients treated by postoperative external radiation therapy and vaginal brachytherapy. The main risk for ovarian failure was found in patients treated by external radiation therapy.

Conclusion(s): Ovarian transposition is a safe and effective procedure for preserving ovarian function in patients treated by a radiosurgical combination. This procedure should be performed in patients <40 years of age with a small invasive cervical carcinoma (<3 cm) treated by initial surgery. In such selected cases, the risk of ovarian metastasis is low.

Keywords

Ovarian transposition
function preservation
cervical cancer
brachytherapy
external radiation therapy

Cited by (0)